Product image of Zemplar (Paricalcitol) supplied by GNH India

Zemplar

Active Ingredient:
Paricalcitol
Origin:
EU

Zemplar (Paricalcitol)

Paricalcitol (Zemplar) is a vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. This intravenous formulation supports calcium balance and bone health. Ideal for dialysis patients requiring PTH regulation. Short-term therapy may be indicated for certain conditions.

Manufacturer / TM Owner

Abbvie Deutschland Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Paricalcitol is primarily used to treat secondary hyperparathyroidism in adults with chronic kidney disease, especially those on dialysis. It helps regulate parathyroid hormone levels to maintain calcium and phosphate balance. The medication is also used to prevent and manage elevated PTH in certain pre-dialysis patients under medical supervision.

Side Effects

  • Paricalcitol works by mimicking the action of vitamin D in the body, which helps control parathyroid hormone secretion. Patients may notice improved calcium levels and reduced bone discomfort over time. Some individuals report better energy levels as their mineral balance stabilizes.

Precautions & Warnings

  • Paricalcitol should be administered under medical supervision due to the risk of elevated calcium levels. Regular blood tests are recommended to monitor calcium, phosphate, and parathyroid hormone levels during treatment. Patients with a history of high calcium should use this medication with caution.

Avoid Interactions

  • Paricalcitol may interact with medications that affect calcium metabolism, such as thiazide diuretics or calcium supplements. CYP3A inhibitors, including certain antifungals and antibiotics, may increase paricalcitol levels. Always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

Paricalcitol is used to treat secondary hyperparathyroidism in patients with chronic kidney disease, particularly those on dialysis.

Paricalcitol is given as an intravenous injection, typically by a healthcare professional in a clinical setting.

Yes, paricalcitol may increase calcium levels, which is why regular monitoring is required during treatment.

Paricalcitol may be used in pre-dialysis patients under medical supervision to manage secondary hyperparathyroidism.

Discuss your full medical history, current medications, and any history of high calcium before starting paricalcitol.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Paricalcitol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT